Member Info for playingtheodds

Thats it in a nutshell , sell if it doesnt do what your decision to buy was made on. Not because you are on a paper loss

Spot on

The SP levels of £4/5 was generated by retail frenzy as is the SP fall. Buys will flood in at some point and then its a hold as market value is established. For me £2 is cheap but im a retail investor with a grain of sand in the game. I will sell IF any bad news because it will confirm my decision to buy was wrong.

For those looking long term the ability of the company to invest without borrowing money is unprecedented. Balance this with the kudos they now have and £1 or £2 now matters not a jot in years to come.

https://www.constructionenquirer.com/2020/06/12/galliford-try-wins-15m-alder-hey-childrens-unit/

It is true gaps get filled without support. BUT the support will be found and the SP will rise to the companies "market" worth thereafter. As retail investors we are gnats on a beasts back. I only play with small stakes because its a game of strategy that you cannot influence.

The winter season will be bedlam. Basically everyone with a cough will need testing , perhaps twice. And then again if not Covid positive throughout the winter when presenting with a cough. Mind boggling numbers

I think there is something bigger going on in market generally. The amount of holdings RNS's seems to have multiplied for all stocks. Hence the supression of prices. Perhaps the general market bubble is about to burst. Any companies that have failed to raise cash or have not profited from Covid could be in a lot of bother. I am now 25% stocks 75% cash. Remaining in Orph , ODX and NCYT.

This when introduced is a game changer and reduces time to get a result significantly. The "change" required from RNA to DNA at present is cumbersome. At least thats how i understand it ?

Is that this govt maybe reluctant to splash the cash for a mass roll out the longer time goes by and perhaps Covid wanes. Otherwise very content.

You have to join
https://www.gotomeeting.com/en-gb/webinar

Bargain .

Some good discussion hopefully later.

He didnt say design freeze was a big hurdle just regulatory and then picked by the govt as a commercial choice. Regulatory is the big hurdle and timescales not immediate

Thats exactly what he said. A long wait in store to commercialisation

Punit This is why imo . But the expected revenues from Covid must be massive to do this

https://www.insider.co.uk/news/omega-diagnostics-takes-8-million-22160668

So this is why its dropped like it did. The expected revenues from Covid must be bigger than i expected
https://www.insider.co.uk/news/omega-diagnostics-takes-8-million-22160668

I think that in 12 months this price will seem a gift So regardless of market swings im here to stay for the future dividends..

Bump to you sir as well

I feel we are further away than we thought. PHE are really upping the ante with respect to validation.